Drug
Tev 48574 Dose Regimen A
Tev 48574 Dose Regimen A: highest development phase Phase 2, developed by Teva Branded Pharmaceutical Products R&D LLC. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Teva Branded Pharmaceutical Products R&D LLC
Trials
| Drug | Phase | Indication |
|---|---|---|
| TEV-48574 Dose Regimen A NCT05668013 | Phase 2 | Crohn Disease |
Latest
No recent events.
Follow Tev 48574 Dose Regimen A on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.